证券之星消息，8月14日医药商业板块较上一交易日下跌1.35%，塞力医疗领跌。当日上证指数报收于 3666.44，下跌0.46%。深证成指报收于11451.43，下跌0.87%。医药商业板块个股涨跌见下表： | 代码 | 名称 | 主力净流入(元) | 主力净占比 游资净流入 (元) | | 游资净占比 散户净流入(元) | | 散户净占比 | | --- | --- | --- | --- | --- | --- | --- | --- | | 603939 | 益丰药房 | 1562.54万 | 9.35% | -99.62万 | -0.60% | -1462.92万 | -8.75% | | 000028 | 国药一致 | 577.41万 | 5.26% | -431.37万 | -3.93% | -146.04万 | -1.33% | | 000411 | 英特集团 | 503.55万 | 6.47% | 507.34万 | 6.52% | -- 1010.88万 | -13.00% | | 002788 | 鹭燕医药 | 240.24万 | 4.17% | 602.82万 | 10.47% | -8 ...

截至2025年8月13日15时，塞力医疗最新股价为31.09元，较前一交易日收盘价上涨1.91元。当日开盘价 为29.04元，最高触及31.31元，最低下探28.59元，成交量为55.62万手，成交金额达16.71亿元。 风险提示：以上内容仅供参考，不构成投资建议。市场有风险，投资需谨慎。 塞力医疗属于医药商业板块，公司主营业务为医疗商业和工业业务。2024年财务数据显示，其商业业务 收入占比达97.09%，工业业务收入占比2.91%。 来源:金融界 8月12日晚间，公司发布公告称实际控制人温伟已办理完成300万股股份的解除质押手续。本次解除质押 后，温伟累计质押股份数降至530万股，占其持股比例的55.01%。公司控股股东及实际控制人合计质押 股份数为1930万股，占公司总股本的10.1%。 8月13日主力资金净流入1.09亿元，占流通市值的1.84%。近五个交易日主力资金累计净流入1.44亿元， 占流通市值的2.42%。 ...

| 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 301408 | 华人健康 | 15.11 | -1.76% | 17.96万 | 2.71亿 | | 300937 | 药易购 | 30.05 | -1.60% | 4.53万 | 1.36亿 | | 301015 | 百洋医药 | 25.98 | -1.55% | 29.18万 | 7.77亿 | | 600272 | 开开实业 | 13.87 | -1.42% | 6.94万 | 9642.32万 | | 301126 | 达嘉维康 | 13.25 | -1.41% | 14.39万 | 1.91亿 | | 603122 | 合富中国 | 7.23 | -1.36% | 6.01万 | 4356.44万 | | 002589 | 瑞康医药 | 3.05 | -1.29% | 43.86万 | 1.34亿 | | 301017 | 款玉平民 | 13.20 | -0.98% | 4.94万 | 6532.05万 | | 605266 | 健之佳 ...

来源：金融界 8月13日，DRG/DIP概念上涨2.42%，今日主力资金流入4.56亿元，概念股13只上涨，6只下跌。 主力资金净流入居前的分别为荣科科技（4.22亿元）、塞力医疗（1.09亿元）、数字认证（7544.17万 元）、东华软件（5875.2万元）、太极股份（5268.54万元）。 序号代码名称最新价涨跌幅主力净流入主力净占比1300290荣科科技22.9220.04.22亿元24.34%2603716塞 力医疗31.096.551.09亿元6.54%3300579数字认证37.759.267544.17万元5.98%4002065东华软件 9.611.85875.20万元3.97%5002368太极股份26.372.615268.54万元7.4%6300078思创医惠4.050.25100.71万 元0.63%7688246嘉和美康35.393.06-1.15万元-0.01%8600718东软集团10.051.01-27.36万元-0.12%9300168 万达信息7.970.38-383.65万元-1.85%10688579山大地纬11.78-0.67-394.36万元-5.69% ...

资金流向方面，今日主力资金净流入1.09亿元，占比成交额6.54%。其中，超大单净流入8233.52万元、 占成交额4.93%，大单净流入2691.33万元、占成交额1.61%，中单净流出流出8469.74万元、占成交额 5.07%，小单净流出2455.11万元、占成交额1.47%。 塞力医疗最新一期业绩显示，截至2025一季报，公司营业总收入2.87亿元、同比减少40.75%，归属净利 润1432.09万元，同比减少553.66%，扣非净利润2846.33万元，同比减少3228.81%，流动比率1.931、速 动比率1.591、资产负债率58.57%。 金融界消息 截至2025年8月13日收盘，塞力医疗（603716）报收于31.09元，上涨6.55%，换手率 29.12%，成交量55.62万手，成交金额16.71亿元。 通过天眼查大数据分析，塞力斯医疗科技集团股份有限公司共对外投资了70家企业，参与招投标项目 146次，知识产权方面有商标信息9条，专利信息7条，此外企业还拥有行政许可26个。 来源：金融界 天眼查商业履历信息显示，塞力斯医疗科技集团股份有限公司，成立于2004年，位于武汉市，是一家以 从事 ...

券商科创债今年来发行规模超过400亿元。头部券商专项支持科技创新领域的力度不断加大。申万宏源、中原证券等券商相继获批债券发行额度。7月A股新 开户196.36万户，同比增长70.5%，环比增长19.27%。截至7月末，今年以来A股累计新开1456.13万户。新增开户数据反映出市场活跃度的提升，为券商业务 发展提供支撑。 创新药概念股再度活跃获政策支持 8月13日，A股市场呈现震荡上行态势。创业板指数表现突出，半日涨幅达到2.81%。沪指突破2024年10月8日高点，创下2021年12月17日以来新高。沪深两 市半日成交额达1.32万亿元，较上个交易日放量1181亿元。券商股盘中出现异动拉升，创新药概念股同步走强，为市场注入新的活力。 券商板块异动拉升显现资金青睐 券商股在盘中表现活跃，国盛金控连续两个交易日涨停。证券板块主力资金净流入28.45亿元，位居各行业板块资金流入榜首位。东方财富全天成交额达 110.44亿元，居全市场第一位。金融科技方向上，中科金财、同花顺、大智慧等个股领涨。 市场上涨期间，券商板块受到资金追捧。背后体现的是"卖斧子"的投资逻辑。过去券商主要依靠佣金收入，现在这把"斧子"的载体正转向 ...

Group 1 - The core viewpoint of the news is that the brain-computer interface concept stocks in the A-share market have shown strong performance, with several companies experiencing significant price increases [1] Group 2 - Company performance highlights include: - Innovation Medical (002173) saw a price increase of 10.00%, with a total market capitalization of 9.995 billion and a year-to-date increase of 184.55% [2] - Pulite (002324) increased by 7.51%, with a market cap of 15.9 billion and a year-to-date increase of 50.88% [2] - Chengyitong (300430) rose by 6.65%, with a market cap of 6.657 billion and a year-to-date increase of 59.67% [2] - Saily Medical (603716) increased by 5.45%, with a market cap of 5.878 billion and a year-to-date increase of 326.18% [2] - Sanbo Brain Science (301293) rose by 3.79%, with a market cap of 12.9 billion and a year-to-date increase of 44.76% [2] - The MACD golden cross signal formation indicates a positive trend for these stocks [1]

证券代码：603716 证券简称：塞力医疗 公告编号：2025-070 债券代码：113601 债券简称：塞力转债 塞力斯医疗科技集团股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: ? 塞力斯医疗科技集团股份有限公司（以下简称"公司"）控股股东赛海 （上海）健康科技有限公司（以下简称"赛海科技"）持有公司 21,642,540 股 无限售条件流通股股票，占公司总股本的 11.33%（截至 2025 年 6 月 30 日总股 本，下同）。赛海科技累计质押公司股份 14,000,000 股，占其持有公司股份比 例为 64.69%，占公司总股本比例为 7.33%。 ? 公司实际控制人温伟先生持有公司股份 9,634,208 股，占公司总股本比 例为 5.04%。近日，温伟先生将其中 3,000,000 股股份办理完成了解除质押登记 手续，本次解除质押手续办理完毕后，温伟先生累计质押公司股份 5,300,000 股，占其持有公司股份比例为 55.01%，占公司总股本比例为 2.77%。 股东名称 温伟 本 ...

Core Points - The company will pay interest on its convertible bonds on August 21, 2025, for the period from August 21, 2024, to August 20, 2025 [1][2] - The total amount of the convertible bonds issued is 543.31 million yuan, with a face value of 100 yuan per bond [1][4] - The coupon rate for the fifth year is set at 2.50%, resulting in an interest payment of 2.50 yuan per bond (before tax) [2][4] Summary by Sections Bond Information - The convertible bonds are named "塞力转债" with a code of 113601, and they can be converted into A-shares of the company [1][4] - The bonds were issued on August 21, 2020, and will mature on August 20, 2026 [1][4] - The bond's initial conversion price was 16.98 yuan per share, while the latest conversion price is 12.00 yuan per share [4] Interest Payment Details - Interest will be paid annually, with the first payment occurring on August 21, 2021 [2][5] - The interest payment dates are as follows: - Record date: August 20, 2025 - Ex-dividend date: August 21, 2025 - Payment date: August 21, 2025 [2][4] Taxation Information - Individual investors are subject to a 20% tax on interest income, resulting in a net payment of 2.00 yuan per bond after tax [6][7] - Non-resident enterprises are exempt from corporate income tax on interest income until December 31, 2025 [7] Contact Information - The company is located at 1310 Jinshan Avenue, Dongxihu District, Wuhan, and can be contacted via email at ir@thalys.net.cn [7][8]

Core Viewpoint - As of August 12, 2025, the stock price of Sely Medical closed at 29.18 yuan, reflecting a decline of 3.89% from the previous trading day, with a trading volume of 1.346 billion yuan and a turnover rate of 23.82% [1] Company Overview - Sely Medical's main business encompasses both the medical commercial and industrial sectors, with the commercial segment accounting for over 97% of its revenue [1] - The company is associated with several concept sectors, including pharmaceutical commerce, Hubei region, and biological vaccines [1] Shareholder Activity - On the evening of August 12, the company announced that its actual controller, Wen Wei, has fully released the pledge on 3 million shares. Following this release, the total pledged shares held by Wen Wei decreased to 5.3 million, representing 55.01% of his total holdings [1] Capital Flow - On August 12, Sely Medical experienced a net outflow of 206 million yuan in principal funds, which accounted for 3.7% of its circulating market value. Over the past five trading days, the cumulative net outflow reached 131 million yuan, representing 2.34% of its circulating market value [1]